FeatureID,Name,Formula,MW,KEGG Pathways,name4plot,C,H,N,O,Cl,S,P,H_to_C,O_to_C,NOSC,GFE,DBE,DBE_O,AI,AI_mod,DBE_AI,Class,gap_status,control_means,treatment_means,log2FC,pval,pval.adj,Comment,isolate
Feature0159,[Similar to: NP-010746; ΔMass: 146.0345 Da],C25 H29 N4 O9 P,560.16598,NA,[Similar to: NP-010746; ΔMass: 146.0345 Da],25,29,4,9,0,0,1,1.16,0.36,-0.16000000000000014,64.86,14,5,0,0.2903225806451613,0,Phenol,No gap,5.0058946235521535,0,-5.0058946235521535,0.040628936484142036,0.8823838686003126,Downregulated,ERLE
Feature0105,"6-Methoxy-1,2,4-benzenetriol",C7 H8 O4,156.04229,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Phenylalanine, tyrosine and tryptophan biosynthesis;Other","6-Methoxy-1,2,4-benzenetriol",7,8,0,4,0,0,0,1.1428571428571428,0.5714285714285714,0,60.3,4,0,0,0.4,0,Phenol,Missing ions,4.867573380326867,0,-4.867573380326867,0.04058312906222369,0.8823838686003126,Downregulated,ERLE
Feature0209,D-lysopine,C9 H18 N2 O4,218.12664,Other,D-lysopine,9,18,2,4,0,0,0,2,0.4444444444444444,-0.44444444444444464,72.96666666666667,2,-2,-1.3333333333333333,-0.4,-4,Protein,No gap,6.55248132046092,0,-6.55248132046092,0.040596423854947584,0.8823838686003126,Downregulated,ERLE
Feature0092,4-Penten-1-amine,C5 H11 N,85.08916,"Protein digestion and absorption;Tropane, piperidine and pyridine alkaloid biosynthesis",4-Penten-1-amine,5,11,1,0,0,0,0,2.2,0,-1.5999999999999996,105.89999999999998,1,1,0,0,0,Lipid,No gap,6.669431900460147,0,-6.669431900460147,0.040587853604790045,0.8823838686003126,Downregulated,ERLE
Feature0029,"(2S)-3-Hydroxy-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)butanoic acid (non-preferred name)",C10 H19 N O8,281.11106,NA,"(2S)-3-Hydroxy-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)butanoic acid (non-preferred name)",10,19,1,8,0,0,0,1.9,0.8,0,60.3,2,-6,-7,-0.6,-7,Carbohydrate,Missing ions,6.823076872690153,0,-6.823076872690153,0.040575756312789826,0.8823838686003126,Downregulated,ERLE
Feature0105,"6-Methoxy-1,2,4-benzenetriol",C7 H8 O4,156.04229,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Phenylalanine, tyrosine and tryptophan biosynthesis;Other","6-Methoxy-1,2,4-benzenetriol",7,8,0,4,0,0,0,1.1428571428571428,0.5714285714285714,0,60.3,4,0,0,0.4,0,Phenol,No gap,4.867573380326867,0,-4.867573380326867,0.04058312906222369,0.8823838686003126,Downregulated,ERLE
Feature0345,Pyrone,C5 H4 O2,96.02111,Metabolic pathways;Microbial metabolism in diverse environments;Other,Pyrone,5,4,0,2,0,0,0,0.8,0.4,0,60.3,4,2,0.6666666666666666,0.75,2,Condensed HC,No gap,6.3192171328349795,0,-6.3192171328349795,0.04064227088045812,0.4470649796850393,Downregulated,ERIN
Feature0215,"DL-2,6-Diaminopimelic acid",C7 H14 N2 O4,190.09538,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;D-Amino acid metabolism;Other,"DL-2,6-Diaminopimelic acid",7,14,2,4,0,0,0,2,0.5714285714285714,0,60.3,2,-2,-4,-0.6666666666666666,-4,Amino Sugar,No gap,15.919357613513474,23.791134903702467,7.871777290188993,0.020708797612699552,0.4470649796850393,Upregulated,ERIN
Feature0199,Choline O-Sulfate,C5 H13 N O4 S,183.05656,ABC transporters,Choline O-Sulfate,5,13,1,4,0,1,0,2.6,0.8,0,60.3,0,-4,6,-4,-6,Other,Missing ions,21.21058743489204,27.40215552335703,6.19156808846499,0.048975722034043746,0.501578946348655,Upregulated,ERIN
Feature0153,[Similar to: Muramic acid; ΔMass: 162.0529 Da],C15 H27 N O12,413.15341,NA,[Similar to: Muramic acid; ΔMass: 162.0529 Da],15,27,1,12,0,0,0,1.8,0.8,0,60.3,3,-9,-5,-0.5,-10,Carbohydrate,Missing ions,10.861226541072748,0,-10.861226541072748,0.008564670949601064,0.4470649796850393,Downregulated,ERIN
Feature0125,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: 87.8796 Da]",C16 H5 O13 P3,497.89405,NA,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: 87.8796 Da]",16,5,0,13,0,0,3,0.3125,0.8125,0.375,49.6125,16,3,NA,1,0,Condensed HC,No gap,18.090021532154253,24.51588540206895,6.425863869914696,0.04539620120065076,0.4815239913069027,Upregulated,ERIN
Feature0335,Pipecolic acid,C6 H11 N O2,129.07898,"Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Tropane, piperidine and pyridine alkaloid biosynthesis;Other",Pipecolic acid-peak2,6,11,1,2,0,0,0,1.8333333333333333,0.3333333333333333,-0.666666666666667,79.30000000000001,2,0,-0.3333333333333333,0,-1,Protein,No gap,6.543476150488953,0,-6.543476150488953,0.0405702804412283,0.4470649796850393,Downregulated,ERIN
Feature0326,N~2~-Acetyl-L-ornithine,C7 H14 N2 O3,174.10047,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Other,N~2~-Acetyl-L-ornithine,7,14,2,3,0,0,0,2,0.42857142857142855,-0.2857142857142856,68.44285714285714,2,-1,-1.5,-0.42857142857142855,-3,Protein,No gap,7.30529220931042,0,-7.30529220931042,0.040569199229894395,0.4470649796850393,Downregulated,ERIN
Feature0323,NP-019811,C6 H7 N O2,125.04764,"Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Tropane, piperidine and pyridine alkaloid biosynthesis;Other",NP-019811,6,7,1,2,0,0,0,1.1666666666666667,0.3333333333333333,0,60.3,4,2,0.3333333333333333,0.5,1,Phenol,No gap,6.79821315704584,0,-6.79821315704584,0.0405863984697347,0.4470649796850393,Downregulated,ERIN
Feature0296,muramic acid,C9 H17 N O7,251.10051,Metabolic pathways;ABC transporters;Other,muramic acid,9,17,1,7,0,0,0,1.8888888888888888,0.7777777777777778,0,60.3,2,-5,-6,-0.5555555555555556,-6,Carbohydrate,No gap,7.405779388350194,0,-7.405779388350194,0.040570332018341315,0.4470649796850393,Downregulated,ERIN
Feature0187,"beta-D-Galactopyranosyl-(1->4)-3,6-anhydro-alpha-L-galactopyranosyl-(1->3)-beta-D-galactopyranose",C18 H30 O15,486.15857,Metabolic pathways;ABC transporters;Other,"beta-D-Galactopyranosyl-(1->4)-3,6-anhydro-alpha-L-galactopyranosyl-(1->3)-beta-D-galactopyranose",18,30,0,15,0,0,0,1.6666666666666667,0.8333333333333334,0,60.3,4,-11,-3.6666666666666665,-0.3333333333333333,-11,Carbohydrate,Missing ions,6.976454149874773,0,-6.976454149874773,0.040575285984817674,0.4470649796850393,Downregulated,ERIN
Feature0175,Adenine,C5 H5 N5,135.05448,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Adenine,5,5,5,0,0,0,0,1,0,2,3.299999999999997,6,6,Inf,Inf,1,Unsaturated HC,No gap,7.251350167273253,0,-7.251350167273253,0.040577028977302684,0.4470649796850393,Downregulated,ERIN
Feature0173,[Similar to: Valylproline; ΔMass: 243.0478 Da],C17 H31 N O13,457.17959,NA,[Similar to: Valylproline; ΔMass: 243.0478 Da],17,31,1,13,0,0,0,1.8235294117647056,0.7647058823529411,-0.117647058823529,63.65294117647058,3,-10,-3.6666666666666665,-0.47368421052631576,-11,Carbohydrate,No gap,7.0365125475078605,0,-7.0365125475078605,0.040572892467457614,0.4470649796850393,Downregulated,ERIN
Feature0167,[Similar to: NP-017684; ΔMass: -96.2336 Da],C25 H40 N4 O18,684.2324,NA,[Similar to: NP-017684; ΔMass: -96.2336 Da],25,40,4,18,0,0,0,1.6,0.72,0.31999999999999984,51.18,8,-10,-4.666666666666667,-0.4166666666666667,-14,Carbohydrate,Missing ions,7.5157243061148336,0,-7.5157243061148336,0.040573759858841006,0.4470649796850393,Downregulated,ERIN
Feature0161,[Similar to: NP-015005; ΔMass: -441.3129 Da],C28 H47 N O14 P2,683.24858,NA,[Similar to: NP-015005; ΔMass: -441.3129 Da]-peak2,28,47,1,14,0,0,2,1.6785714285714286,0.5,-0.9285714285714288,86.76428571428572,7,-7,-0.9090909090909092,-0.16666666666666666,-10,Protein,No gap,7.288185562601154,0,-7.288185562601154,0.040569875098711815,0.4470649796850393,Downregulated,ERIN
Feature0160,[Similar to: NP-015005; ΔMass: -441.3129 Da],C25 H41 N5 O17,683.24859,NA,[Similar to: NP-015005; ΔMass: -441.3129 Da]-peak1,25,41,5,17,0,0,0,1.64,0.68,0.31999999999999984,51.18,8,-9,-4.666666666666667,-0.4782608695652174,-14,Amino Sugar,No gap,7.05330585956102,0,-7.05330585956102,0.0405699119066142,0.4470649796850393,Downregulated,ERIN
Feature0156,[Similar to: N-Acetylneuraminic acid; ΔMass: 120.0423 Da],C16 H23 N5 O9,429.1483,NA,[Similar to: N-Acetylneuraminic acid; ΔMass: 120.0423 Da],16,23,5,9,0,0,0,1.4375,0.5625,0.625,42.4875,8,-1,-3,-0.2307692307692308,-6,Phenol,No gap,6.33540854017646,0,-6.33540854017646,0.040570187382292594,0.4470649796850393,Downregulated,ERIN
Feature0153,[Similar to: Muramic acid; ΔMass: 162.0529 Da],C15 H27 N O12,413.15341,NA,[Similar to: Muramic acid; ΔMass: 162.0529 Da],15,27,1,12,0,0,0,1.8,0.8,0,60.3,3,-9,-5,-0.5,-10,Carbohydrate,No gap,10.861226541072748,0,-10.861226541072748,0.008564670949601064,0.4470649796850393,Downregulated,ERIN
Feature0141,"[Similar to: [(2R,3S,4S,5R,6R)-6-{[(2R,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-3,4-dihydroxy-5-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]methyl (2E)-2-methylbut-2-enoate; ΔMass: -42.0492 Da]",C30 H44 O15 P2,706.21457,NA,"[Similar to: [(2R,3S,4S,5R,6R)-6-{[(2R,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-3,4-dihydroxy-5-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]methyl (2E)-2-methylbut-2-enoate; ΔMass: -42.0492 Da]",30,44,0,15,0,0,2,1.4666666666666666,0.5,-0.7999999999999998,83.1,10,-5,-0.5384615384615384,0.02439024390243902,-7,Phenol,No gap,6.63316416074046,0,-6.63316416074046,0.0406070998211436,0.4470649796850393,Downregulated,ERIN
Feature0137,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]",C8 H14 N6 O5,274.10288,NA,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]-peak2",8,14,6,5,0,0,0,1.75,0.625,1.75,10.424999999999995,5,0,2,7,-6,Amino Sugar,No gap,8.08338437323972,0,-8.08338437323972,0.019194923688183246,0.4470649796850393,Downregulated,ERIN
Feature0129,"[Similar to: 3-{[(1,5-Dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)amino]carbonyl}-2-pyrazinecarboxylic acid; ΔMass: 136.0723 Da]",C21 H31 N O12,489.18466,NA,"[Similar to: 3-{[(1,5-Dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)amino]carbonyl}-2-pyrazinecarboxylic acid; ΔMass: 136.0723 Da]",21,31,1,12,0,0,0,1.4761904761904765,0.5714285714285714,-0.1904761904761907,65.72857142857143,7,-5,-0.75,0,-6,Phenol,No gap,7.0847800513438335,0,-7.0847800513438335,0.04056963807467989,0.4470649796850393,Downregulated,ERIN
Feature0128,[Similar to: 3-[1-(dimethylamino)-1H-pyrrol-2-yl]-2-(2-furylcarbonyl)acrylonitrile; ΔMass: 200.0995 Da],C19 H29 N5 O8,455.20029,NA,[Similar to: 3-[1-(dimethylamino)-1H-pyrrol-2-yl]-2-(2-furylcarbonyl)acrylonitrile; ΔMass: 200.0995 Da],19,29,5,8,0,0,0,1.5263157894736843,0.42105263157894735,0.10526315789473673,57.3,8,0,-0.8333333333333334,-0.1,-5,Protein,No gap,9.557153932993153,0,-9.557153932993153,0.019188560763779918,0.4470649796850393,Downregulated,ERIN
Feature0097,"5-hydroxy-4-methoxy-5,6-dihydro-2H-pyran-2-one",C6 H8 O4,144.04224,Microbial metabolism in diverse environments;Other,"5-hydroxy-4-methoxy-5,6-dihydro-2H-pyran-2-one",6,8,0,4,0,0,0,1.3333333333333333,0.6666666666666666,0,60.3,3,-1,-0.5,0.25,-1,Other,No gap,7.27044535962158,0,-7.27044535962158,0.04058322873776916,0.4470649796850393,Downregulated,ERIN
Feature0050,2'-Deoxyadenosine,C10 H13 N5 O3,251.10189,Metabolic pathways;ABC transporters;Other,2'-Deoxyadenosine-peak2,10,13,5,3,0,0,0,1.3,0.3,0.7999999999999998,37.5,7,4,-0.5,0.14285714285714285,-1,Phenol,Missing ions,18.879864395160954,26.556979769854383,7.677115374693429,0.0250111366652666,0.4470649796850393,Upregulated,ERIN
Feature0032,"(6R)-5-Acetamido-3,5-dideoxy-6-[(1R,2R)-1,2-dihydroxy-3-(lactoyloxy)propyl]-alpha-L-threo-hex-2-ulopyranosonic acid",C14 H23 N O11,381.12721,NA,"(6R)-5-Acetamido-3,5-dideoxy-6-[(1R,2R)-1,2-dihydroxy-3-(lactoyloxy)propyl]-alpha-L-threo-hex-2-ulopyranosonic acid",14,23,1,11,0,0,0,1.6428571428571428,0.7857142857142857,0.1428571428571428,56.22857142857143,4,-7,-4,-0.3333333333333333,-8,Carbohydrate,No gap,6.409288109528534,0,-6.409288109528534,0.04058422599432806,0.4470649796850393,Downregulated,ERIN
Feature0022,NA,C16 H29 N O13,443.16395,NA,Feature0022,16,29,1,13,0,0,0,1.8125,0.8125,0,60.3,3,-10,-5.5,-0.5294117647058824,-11,Carbohydrate,No gap,6.74329404714238,0,-6.74329404714238,0.04057216277677382,0.4470649796850393,Downregulated,ERIN
Feature0021,NA,C18 H25 N5 O10,471.15896,NA,Feature0021,18,25,5,10,0,0,0,1.3888888888888888,0.5555555555555556,0.5555555555555554,44.46666666666667,9,-1,-2,-0.125,-6,Phenol,No gap,6.89182782908096,0,-6.89182782908096,0.040574360026035136,0.4470649796850393,Downregulated,ERIN
Feature0014,NA,C18 H34 N2 O12,470.2113,NA,Feature0014,18,34,2,12,0,0,0,1.8888888888888888,0.6666666666666666,-0.22222222222222232,66.63333333333333,3,-9,-2.75,-0.5,-11,Amino Sugar,No gap,6.3411909223710605,0,-6.3411909223710605,0.04056868823131518,0.4470649796850393,Downregulated,ERIN
Feature0011,NA,C16 H28 N2 O13,456.15919,NA,Feature0011,16,28,2,13,0,0,0,1.75,0.8125,0.25,53.175,4,-9,-11,-0.6,-11,Carbohydrate,No gap,5.96033415183376,0,-5.96033415183376,0.04059512401215118,0.4470649796850393,Downregulated,ERIN
Feature0009,NA,C22 H39 N O17,589.22211,NA,Feature0009,22,39,1,17,0,0,0,1.7727272727272727,0.7727272727272727,-0.09090909090909084,62.89090909090909,4,-13,-3.5,-0.44,-14,Carbohydrate,No gap,6.160539202694033,0,-6.160539202694033,0.040574074204069985,0.4470649796850393,Downregulated,ERIN
Feature0050,2'-Deoxyadenosine,C10 H13 N5 O3,251.10189,Metabolic pathways;ABC transporters;Other,2'-Deoxyadenosine-peak2,10,13,5,3,0,0,0,1.3,0.3,0.7999999999999998,37.5,7,4,-0.5,0.14285714285714285,-1,Phenol,No gap,18.879864395160954,26.556979769854383,7.677115374693429,0.0250111366652666,0.4470649796850393,Upregulated,ERIN
Feature0167,[Similar to: NP-017684; ΔMass: -96.2336 Da],C25 H40 N4 O18,684.2324,NA,[Similar to: NP-017684; ΔMass: -96.2336 Da],25,40,4,18,0,0,0,1.6,0.72,0.31999999999999984,51.18,8,-10,-4.666666666666667,-0.4166666666666667,-14,Carbohydrate,No gap,7.5157243061148336,0,-7.5157243061148336,0.040573759858841006,0.4470649796850393,Downregulated,ERIN
Feature0128,[Similar to: 3-[1-(dimethylamino)-1H-pyrrol-2-yl]-2-(2-furylcarbonyl)acrylonitrile; ΔMass: 200.0995 Da],C19 H29 N5 O8,455.20029,NA,[Similar to: 3-[1-(dimethylamino)-1H-pyrrol-2-yl]-2-(2-furylcarbonyl)acrylonitrile; ΔMass: 200.0995 Da],19,29,5,8,0,0,0,1.5263157894736843,0.42105263157894735,0.10526315789473673,57.3,8,0,-0.8333333333333334,-0.1,-5,Protein,Missing ions,9.557153932993153,0,-9.557153932993153,0.019188560763779918,0.4470649796850393,Downregulated,ERIN
Feature0338,Proline,C5 H9 N O2,115.06328,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Other,Proline,5,9,1,2,0,0,0,1.8,0.4,-0.4000000000000003,71.7,2,0,-0.5,0,-1,Protein,No gap,28.956147540780947,27.830001434934882,-1.1261461058460647,0.04287202080681035,0.9176985427155225,Downregulated,BOCU
Feature0023,NA,C2 H3 P S,89.96937,NA,Feature0023,2,3,0,0,0,1,1,1.5,0,-3,145.8,2,2,NA,NA,0,Lipid,No gap,17.454039818794534,4.3558948219668006,-13.098144996827735,0.03526456674484958,0.9176985427155225,Downregulated,BOCU
Feature0360,Valine,C5 H11 N O2,117.07893,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Cyanoamino acid metabolism;Other,Valine,5,11,1,2,0,0,0,2.2,0.4,-0.7999999999999998,83.1,1,-1,-1,-0.3333333333333333,-2,Protein,No gap,27.85615625129244,27.468820006622416,-0.38733624467002414,0.0392812524030271,0.9176985427155225,Downregulated,BOCU
Feature0363,Υ-Aminobutyric acid (GABA),C4 H9 N O2,103.06331,Metabolic pathways;Microbial metabolism in diverse environments;Other,Υ-Aminobutyric acid (GABA),4,9,1,2,0,0,0,2.25,0.5,-0.5,74.55,1,-1,-2,-0.5,-2,Protein,Missing ions,12.750827882587899,4.560006332202266,-8.190821550385632,0.1864671127684897,0.939741959353124,Downregulated,LEDU
Feature0343,Pyrogallol,C6 H6 O3,126.03166,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Other,Pyrogallol,6,6,0,3,0,0,0,1,0.5,0,60.3,4,1,0.3333333333333333,0.5555555555555556,1,Phenol,No gap,3.1330891393294134,0,-3.1330891393294134,0.16483994012557268,0.939741959353124,Downregulated,LEDU
Feature0338,Proline,C5 H9 N O2,115.06328,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Other,Proline,5,9,1,2,0,0,0,1.8,0.4,-0.4000000000000003,71.7,2,0,-0.5,0,-1,Protein,No gap,28.956147540780947,28.150002268640783,-0.8061452721401636,0.11374225232182118,0.939741959353124,Downregulated,LEDU
Feature0317,NP-007065,C8 H10 O3,154.06301,Microbial metabolism in diverse environments;Other,NP-007065,8,10,0,3,0,0,0,1.25,0.375,-0.5,74.55,4,1,0.2,0.38461538461538464,1,Phenol,No gap,2.414180400551,6.414949067417683,4.0007686668666835,0.3949151806909742,0.939741959353124,Upregulated,LEDU
Feature0309,N-Methyl-Nâ€²-piperazinoacetohydrazide,C7 H16 N4 O,172.13244,NA,N-Methyl-Nâ€²-piperazinoacetohydrazide-peak2,7,16,4,1,0,0,0,2.2857142857142856,0.14285714285714285,-0.2857142857142856,68.44285714285714,2,1,-1.5,-1,-3,Lipid,No gap,1.3411444947673,6.063535164930733,4.722390670163433,0.2908447809143919,0.939741959353124,Upregulated,LEDU
Feature0251,L-Phenylalanine,C9 H11 N O2,165.07901,"Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;ABC transporters;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Protein digestion and absorption;Phenylalanine, tyrosine and tryptophan biosynthesis;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Tropane, piperidine and pyridine alkaloid biosynthesis;Biosynthesis of various plant secondary metabolites;D-Amino acid metabolism;Cyanoamino acid metabolism;Other",L-Phenylalanine,9,11,1,2,0,0,0,1.2222222222222223,0.2222222222222222,-0.44444444444444464,72.96666666666667,5,3,0.3333333333333333,0.42857142857142855,2,Phenol,Missing ions,29.394605703441886,29.567130579703317,0.17252487626143065,0.38513059740171796,0.939741959353124,Upregulated,LEDU
Feature0246,L-Glutamic acid,C5 H9 N O4,147.05318,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Cyanoamino acid metabolism;Other,L-Glutamic acid,5,9,1,4,0,0,0,1.8,0.8,0.3999999999999999,48.9,2,-2,-Inf,-0.5,-3,Carbohydrate,Missing ions,25.26034915910078,19.37141090060812,-5.8889382584926615,0.4070720994689947,0.939741959353124,Downregulated,LEDU
Feature0242,L-alpha-Glycerylphosphorylcholine,C8 H20 N O6 P,257.10283,NA,L-alpha-Glycerylphosphorylcholine,8,20,1,6,0,0,1,2.5,0.75,-1.25,95.925,0,-6,-Inf,-1.6666666666666667,-8,Carbohydrate,Missing ions,29.388005646622275,29.47179648394515,0.08379083732287285,0.384125932529748,0.939741959353124,Upregulated,LEDU
Feature0218,DL-Carnitine,C7 H15 N O3,161.10522,Other,DL-Carnitine,7,15,1,3,0,0,0,2.142857142857143,0.42857142857142855,-0.8571428571428568,84.72857142857141,1,-2,-1,-0.3333333333333333,-3,Protein,No gap,14.2914546478425,22.440737526869498,8.149282879026998,0.1771805767626356,0.939741959353124,Upregulated,LEDU
Feature0216,DL-Arginine,C6 H14 N4 O2,174.1118,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Other,DL-Arginine,6,14,4,2,0,0,0,2.3333333333333335,0.3333333333333333,0.3333333333333335,50.8,2,0,-Inf,-3,-4,Other,Missing ions,23.024848911928192,26.867941026911765,3.8430921149835733,0.13466134806971955,0.939741959353124,Upregulated,LEDU
Feature0201,Cyclo(leucylprolyl),C11 H18 N2 O2,210.13681,NA,Cyclo(leucylprolyl),11,18,2,2,0,0,0,1.6363636363636365,0.18181818181818185,-0.7272727272727275,81.02727272727273,4,2,0,0.125,0,Lipid,No gap,27.370391268645506,27.2654236637037,-0.10496760494180535,0.2604192955130364,0.939741959353124,Downregulated,LEDU
Feature0199,Choline O-Sulfate,C5 H13 N O4 S,183.05656,ABC transporters,Choline O-Sulfate,5,13,1,4,0,1,0,2.6,0.8,0,60.3,0,-4,6,-4,-6,Other,Missing ions,21.21058743489204,26.82309977871642,5.612512343824378,0.06948169246080318,0.939741959353124,Upregulated,LEDU
Feature0194,C16 phytosphingosine,C16 H35 N O3,289.26171,NA,C16 phytosphingosine,16,35,1,3,0,0,0,2.1875,0.1875,-1.625,106.6125,0,-3,-0.3333333333333333,-0.18518518518518515,-4,Lipid,No gap,3.352765566015193,8.381913915037984,5.02914834902279,0.4127616681271179,0.939741959353124,Upregulated,LEDU
Feature0188,Betaine,C5 H11 N O2,117.07895,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Cyanoamino acid metabolism;Other,Betaine,5,11,1,2,0,0,0,2.2,0.4,-0.7999999999999998,83.1,1,-1,-1,-0.3333333333333333,-2,Protein,No gap,30.3913325110869,29.9505642317593,-0.44076827932759954,0.1458289235306097,0.939741959353124,Downregulated,LEDU
Feature0172,[Similar to: Trimethoprim impurity C; ΔMass: 188.0284 Da],C24 H32 O7 P2,494.16122,NA,[Similar to: Trimethoprim impurity C; ΔMass: 188.0284 Da],24,32,0,7,0,0,2,1.3333333333333333,0.2916666666666667,-1.166666666666667,93.55,10,3,0.06666666666666667,0.24324324324324328,1,Phenol,No gap,20.974476148794786,16.2348597300653,-4.7396164187294865,0.4497867660996687,0.939741959353124,Downregulated,LEDU
Feature0147,[Similar to: diethyl 2-({2-[2-(methoxycarbonyl)-3-thienyl]hydrazino}methylene)malonate; ΔMass: -124.1122 Da],C3 H7 Cl N2 O5 S,217.97633,NA,[Similar to: diethyl 2-({2-[2-(methoxycarbonyl)-3-thienyl]hydrazino}methylene)malonate; ΔMass: -124.1122 Da],4,7,2,5,1,1,0,1.75,1.25,2.75,-18.075000000000003,2.5,-2.5,1.375,2,-5.5,Carbohydrate,No gap,27.304807756926113,26.76827176864385,-0.5365359882822638,0.06484593896147167,0.939741959353124,Downregulated,LEDU
Feature0122,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: -184.0702 Da]",C3 H3 N2 O6 P S,225.94422,Metabolic pathways;Microbial metabolism in diverse environments;Other,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: -184.0702 Da]",3,3,2,6,0,1,1,1,2,4,-53.7,4,-2,0.8571428571428571,0.75,-6,Other,No gap,27.670559559755368,27.462763015251316,-0.2077965445040526,0.15431726952473485,0.939741959353124,Downregulated,LEDU
Feature0105,"6-Methoxy-1,2,4-benzenetriol",C7 H8 O4,156.04229,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Phenylalanine, tyrosine and tryptophan biosynthesis;Other","6-Methoxy-1,2,4-benzenetriol",7,8,0,4,0,0,0,1.1428571428571428,0.5714285714285714,0,60.3,4,0,0,0.4,0,Phenol,Missing ions,4.867573380326867,9.092511416449717,4.22493803612285,0.38563042722764407,0.939741959353124,Upregulated,LEDU
Feature0077,3-oxovaleric acid,C5 H8 O3,116.04729,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;Other,3-oxovaleric acid,5,8,0,3,0,0,0,1.6,0.6,-0.4000000000000003,71.7,2,-1,-0.5,0.14285714285714285,-1,Amino Sugar,No gap,1.5806306460482868,0,-1.5806306460482868,0.33428194339465733,0.939741959353124,Downregulated,LEDU
Feature0069,3-Carboxytyrosine,C10 H11 N O5,225.0637,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Other,3-Carboxytyrosine,10,11,1,5,0,0,0,1.1,0.5,0.20000000000000015,54.599999999999994,6,1,0,0.38461538461538464,0,Phenol,No gap,2.3451390673758867,5.54644451889745,3.201305451521563,0.4334322272554614,0.939741959353124,Upregulated,LEDU
Feature0025,NA,C4 H2 O8 S2,241.91814,NA,Feature0025,4,2,0,8,0,2,0,0.5,2,4.5,-67.95,4,-4,1,1,-6,Other,No gap,26.770587226404274,26.5602246354593,-0.21036259094497467,0.07861378936145987,0.939741959353124,Downregulated,LEDU
Feature0013,NA,C3 H2 N4 O18 S2,445.88051,NA,Feature0013,3,2,4,18,0,2,0,0.6666666666666666,6,16.666666666666664,-414.69999999999993,5,-13,0.9047619047619048,0.8333333333333334,-19,Other,No gap,10.040554766159227,4.37619814143795,-5.664356624721277,0.322933652288376,0.939741959353124,Downregulated,LEDU
Feature0006,NA,C9 H9 N2 O6 P3 S4,461.85452,NA,Feature0006,9,9,2,6,0,4,3,1,0.6666666666666666,0.22222222222222232,53.96666666666666,8,2,1.1666666666666667,1.3333333333333333,-7,Other,No gap,3.10891906098036,8.3346660324824,5.225746971502039,0.3905929116678094,0.939741959353124,Upregulated,LEDU
Feature0360,Valine,C5 H11 N O2,117.07893,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Cyanoamino acid metabolism;Other,Valine,5,11,1,2,0,0,0,2.2,0.4,-0.7999999999999998,83.1,1,-1,-1,-0.3333333333333333,-2,Protein,No gap,27.85615625129244,27.76349887543975,-0.09265737585268852,0.41798032470595703,0.939741959353124,Downregulated,LEDU
Feature0330,"pentane-1,2,3,4,5-pentol",C5 H12 O5,152.06848,Metabolic pathways;ABC transporters;Other,"pentane-1,2,3,4,5-pentol",5,12,0,5,0,0,0,2.4,1,-0.4000000000000003,71.7,0,-5,-Inf,-1,-5,Carbohydrate,No gap,2.9533069279352135,8.891410919079133,5.93810399114392,0.356623546321714,0.939741959353124,Upregulated,LEDU
Feature0278,Methionine,C5 H11 N O2 S,149.05106,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Biosynthesis of various plant secondary metabolites;D-Amino acid metabolism;Other,Methionine,5,11,1,2,0,1,0,2.2,0.4,-0.4000000000000003,71.7,1,-1,-3,-1,-3,Protein,No gap,8.040827052141294,12.676660937547418,4.635833885406123,0.4921774347577341,0.939741959353124,Upregulated,LEDU
Feature0277,methallylamine,C4 H9 N,71.07352,NA,methallylamine,4,9,1,0,0,0,0,2.25,0,-1.5,103.05,1,1,0,0,0,Lipid,No gap,15.35685870939146,21.292675450273784,5.9358167408823235,0.29580387749354553,0.939741959353124,Upregulated,LEDU
Feature0255,L-Threonine,C4 H9 N O3,119.05821,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;D-Amino acid metabolism;Other,L-Threonine,4,9,1,3,0,0,0,2.25,0.75,0,60.3,1,-2,-Inf,-1,-3,Carbohydrate,No gap,8.636659267220873,4.298224418100967,-4.338434849119906,0.43837663256483383,0.939741959353124,Downregulated,LEDU
Feature0251,L-Phenylalanine,C9 H11 N O2,165.07901,"Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;ABC transporters;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Protein digestion and absorption;Phenylalanine, tyrosine and tryptophan biosynthesis;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Tropane, piperidine and pyridine alkaloid biosynthesis;Biosynthesis of various plant secondary metabolites;D-Amino acid metabolism;Cyanoamino acid metabolism;Other",L-Phenylalanine,9,11,1,2,0,0,0,1.2222222222222223,0.2222222222222222,-0.44444444444444464,72.96666666666667,5,3,0.3333333333333333,0.42857142857142855,2,Phenol,No gap,29.394605703441886,29.567130579703317,0.17252487626143065,0.38513059740171796,0.939741959353124,Upregulated,LEDU
Feature0242,L-alpha-Glycerylphosphorylcholine,C8 H20 N O6 P,257.10283,NA,L-alpha-Glycerylphosphorylcholine,8,20,1,6,0,0,1,2.5,0.75,-1.25,95.925,0,-6,-Inf,-1.6666666666666667,-8,Carbohydrate,No gap,29.388005646622275,29.47179648394515,0.08379083732287285,0.384125932529748,0.939741959353124,Upregulated,LEDU
Feature0219,DL-Stachydrine,C7 H13 N O2,143.09464,ABC transporters,DL-Stachydrine,7,13,1,2,0,0,0,1.8571428571428572,0.2857142857142857,-0.8571428571428568,84.72857142857141,2,0,-0.25,0,-1,Lipid,No gap,4.376487175691587,8.716951069989516,4.34046389429793,0.4925019479925197,0.939741959353124,Upregulated,LEDU
Feature0216,DL-Arginine,C6 H14 N4 O2,174.1118,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Other,DL-Arginine,6,14,4,2,0,0,0,2.3333333333333335,0.3333333333333333,0.3333333333333335,50.8,2,0,-Inf,-3,-4,Other,No gap,23.024848911928192,26.867941026911765,3.8430921149835733,0.13466134806971955,0.939741959353124,Upregulated,LEDU
Feature0195,Caffeic acid,C9 H8 O4,180.04228,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Degradation of aromatic compounds;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Caffeic acid,9,8,0,4,0,0,0,0.8888888888888888,0.4444444444444444,0,60.3,6,2,0.4,0.5714285714285714,2,Phenol,No gap,2.65654672462394,0,-2.65654672462394,0.16462917465681362,0.939741959353124,Downregulated,LEDU
Feature0193,Butyl glyoxylate,C6 H10 O3,130.06295,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Degradation of aromatic compounds;Other,Butyl glyoxylate,6,10,0,3,0,0,0,1.6666666666666667,0.5,-0.666666666666667,79.30000000000001,2,-1,-0.3333333333333333,0.1111111111111111,-1,Protein,No gap,1.3113321610880533,0,-1.3113321610880533,0.33428194339465733,0.939741959353124,Downregulated,LEDU
Feature0149,[Similar to: Dimethyl phosphate; ΔMass: 60.0212 Da],C4 H11 O6 P,186.02936,NA,[Similar to: Dimethyl phosphate; ΔMass: 60.0212 Da],4,11,0,6,0,0,1,2.75,1.5,-1,88.8,0,-6,2.3333333333333335,-Inf,-7,Other,No gap,0,3.32122302109195,3.32122302109195,0.36321746764912255,0.939741959353124,Upregulated,LEDU
Feature0147,[Similar to: diethyl 2-({2-[2-(methoxycarbonyl)-3-thienyl]hydrazino}methylene)malonate; ΔMass: -124.1122 Da],C3 H7 Cl N2 O5 S,217.97633,NA,[Similar to: diethyl 2-({2-[2-(methoxycarbonyl)-3-thienyl]hydrazino}methylene)malonate; ΔMass: -124.1122 Da],4,7,2,5,1,1,0,1.75,1.25,2.75,-18.075000000000003,2.5,-2.5,1.375,2,-5.5,Carbohydrate,Missing ions,27.304807756926113,26.76827176864385,-0.5365359882822638,0.06484593896147167,0.939741959353124,Downregulated,LEDU
Feature0114,"[Similar to: (2S,4R,5S,6S,7R)-5,6,12,14-tetrahydroxy-4-(hydroxymethyl)-13-methoxy-3,8-dioxatricyclo[8.4.0.0Â?,â·]tetradeca-1(14),10,12-trien-9-one; ΔMass: -36.0235 Da]",C11 H19 O3 P3,292.05592,NA,"[Similar to: (2S,4R,5S,6S,7R)-5,6,12,14-tetrahydroxy-4-(hydroxymethyl)-13-methoxy-3,8-dioxatricyclo[8.4.0.0Â?,â·]tetradeca-1(14),10,12-trien-9-one; ΔMass: -36.0235 Da]-peak2",11,19,0,3,0,0,3,1.7272727272727273,0.2727272727272727,-2.545454545454546,132.84545454545457,4,1,-0.4,-0.07692307692307693,-2,Lipid,No gap,1.2947463599859668,0,-1.2947463599859668,0.33428194339465733,0.939741959353124,Downregulated,LEDU
Feature0098,5-Methylhexan-3-one,C8 H15 N O4,189.10013,NA,5-Methylhexan-3-one,8,15,1,4,0,0,0,1.875,0.5,-0.5,74.55,2,-2,-1,-0.2,-3,Protein,No gap,3.0791889920101334,0,-3.0791889920101334,0.1643315487065548,0.939741959353124,Downregulated,LEDU
Feature0094,"5-acetamido-3,5-dideoxy-L-arabino-hept-2-ulopyranosonic acid",C9 H15 N O7,249.08483,NA,"5-acetamido-3,5-dideoxy-L-arabino-hept-2-ulopyranosonic acid",9,15,1,7,0,0,0,1.6666666666666667,0.7777777777777778,0.22222222222222232,53.96666666666666,3,-4,-5,-0.3333333333333333,-5,Carbohydrate,Missing ions,1.7345261538421866,0,-1.7345261538421866,0.33428194339465733,0.939741959353124,Downregulated,LEDU
Feature0053,"2,4-Pentadienoic acid",C5 H6 O2,98.03676,Microbial metabolism in diverse environments;Other,"2,4-Pentadienoic acid",5,6,0,2,0,0,0,1.2,0.4,-0.4000000000000003,71.7,3,1,0.3333333333333333,0.5,1,Phenol,No gap,0,8.0391391003324,8.0391391003324,0.17469438426607872,0.939741959353124,Upregulated,LEDU
Feature0312,Ne-Acetyllysine,C8 H16 N2 O3,188.11612,Metabolic pathways;Other,Ne-Acetyllysine,8,16,2,3,0,0,0,2,0.375,-0.5,74.55,2,-1,-1,-0.3333333333333333,-3,Protein,No gap,8.030455572726007,4.095788911361283,-3.934666661364724,0.45674023850625267,0.939741959353124,Downregulated,LEDU
Feature0257,Lactamide,C3 H7 N O2,89.04769,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Cyanoamino acid metabolism;Other,Lactamide,3,7,1,2,0,0,0,2.3333333333333335,0.6666666666666666,0,60.3,1,-1,-Inf,-1,-2,Other,No gap,17.812889388485246,22.204324265128932,4.391434876643686,0.44724775554997154,0.939741959353124,Upregulated,LEDU
Feature0163,[Similar to: NP-016755; ΔMass: -960.7865 Da],C6 H4 N10,216.06097,NA,[Similar to: NP-016755; ΔMass: -960.7865 Da]-peak1,6,4,10,0,0,0,0,0.6666666666666666,0,4.333333333333333,-63.19999999999999,10,10,-0,-0,0,Condensed HC,No gap,18.378473572833993,12.687152282272184,-5.69132129056181,0.40025757746494495,0.939741959353124,Downregulated,LEDU
Feature0125,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: 87.8796 Da]",C16 H5 O13 P3,497.89405,NA,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: 87.8796 Da]",16,5,0,13,0,0,3,0.3125,0.8125,0.375,49.6125,16,3,NA,1,0,Condensed HC,No gap,18.090021532154253,12.2540440001624,-5.835977531991853,0.37488234188931113,0.939741959353124,Downregulated,LEDU
Feature0363,Υ-Aminobutyric acid (GABA),C4 H9 N O2,103.06331,Metabolic pathways;Microbial metabolism in diverse environments;Other,Υ-Aminobutyric acid (GABA),4,9,1,2,0,0,0,2.25,0.5,-0.5,74.55,1,-1,-2,-0.5,-2,Protein,No gap,12.750827882587899,4.560006332202266,-8.190821550385632,0.1864671127684897,0.939741959353124,Downregulated,LEDU
Feature0290,MFCD00025555,C9 H18 N2 O3,202.1317,NA,MFCD00025555,9,18,2,3,0,0,0,2,0.3333333333333333,-0.666666666666667,79.30000000000001,2,-1,-0.75,-0.2727272727272727,-3,Protein,No gap,13.875266690165846,4.299076326446917,-9.57619036371893,0.10895465906131581,0.939741959353124,Downregulated,LEDU
Feature0137,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]",C8 H14 N6 O5,274.10288,NA,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]-peak2",8,14,6,5,0,0,0,1.75,0.625,1.75,10.424999999999995,5,0,2,7,-6,Amino Sugar,No gap,8.08338437323972,4.005680808375083,-4.077703564864637,0.43520517612486165,0.939741959353124,Downregulated,LEDU
Feature0128,[Similar to: 3-[1-(dimethylamino)-1H-pyrrol-2-yl]-2-(2-furylcarbonyl)acrylonitrile; ΔMass: 200.0995 Da],C19 H29 N5 O8,455.20029,NA,[Similar to: 3-[1-(dimethylamino)-1H-pyrrol-2-yl]-2-(2-furylcarbonyl)acrylonitrile; ΔMass: 200.0995 Da],19,29,5,8,0,0,0,1.5263157894736843,0.42105263157894735,0.10526315789473673,57.3,8,0,-0.8333333333333334,-0.1,-5,Protein,No gap,9.557153932993153,4.7576272208253165,-4.799526712167836,0.4385650124478464,0.939741959353124,Downregulated,LEDU
Feature0106,"7-(tert-butyl)-4-imino-1,2,3,4,5,6-hexahydropyrido[3,4-d]pyridazine-1,5-dione",C11 H14 N4 O2,234.11166,NA,"7-(tert-butyl)-4-imino-1,2,3,4,5,6-hexahydropyrido[3,4-d]pyridazine-1,5-dione",11,14,4,2,0,0,0,1.2727272727272727,0.18181818181818185,0.18181818181818168,55.11818181818182,7,5,0.2,0.3333333333333333,1,Phenol,No gap,11.560997441903414,7.46527914920025,-4.095718292703164,0.49477776678910523,0.939741959353124,Downregulated,LEDU
Feature0064,"3,4-Methylenedioxy-N-propylamphetamine",C13 H19 N O2,221.14159,NA,"3,4-Methylenedioxy-N-propylamphetamine-peak1",13,19,1,2,0,0,0,1.4615384615384617,0.15384615384615383,-0.9230769230769234,86.6076923076923,5,3,0.2,0.2727272727272727,2,Phenol,No gap,20.001886597857467,13.666494017698383,-6.335392580159084,0.3863128726818361,0.939741959353124,Downregulated,LEDU
Feature0003,NA,C3 H5 N2 P S,131.99089,NA,Feature0003,3,5,2,0,0,1,1,1.6666666666666667,0,-0.666666666666667,79.30000000000001,3,3,1,1,-1,Lipid,No gap,7.842316662258707,3.8893190283015335,-3.9529976339571733,0.4357891857790882,0.939741959353124,Downregulated,LEDU
Feature0308,N-Methyl-Nâ€²-piperazinoacetohydrazide,C7 H16 N4 O,172.13243,NA,N-Methyl-Nâ€²-piperazinoacetohydrazide-peak1,7,16,4,1,0,0,0,2.2857142857142856,0.14285714285714285,-0.2857142857142856,68.44285714285714,2,1,-1.5,-1,-3,Lipid,No gap,7.425655778159833,3.6539030408016835,-3.77175273735815,0.4300478188547685,0.939741959353124,Downregulated,LEDU
Feature0258,Lauramide,C12 H25 N O,199.19362,NA,Lauramide,12,25,1,1,0,0,0,2.0833333333333335,0.08333333333333333,-1.666666666666667,107.8,1,0,-0.1,-0.04761904761904761,-1,Lipid,No gap,1.6507516803612134,0,-1.6507516803612134,0.33428194339465744,0.939741959353124,Downregulated,LEDU
Feature0183,Asparagine,C4 H8 N2 O3,132.05347,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Cyanoamino acid metabolism;Other,Asparagine,4,8,2,3,0,0,0,2,0.75,1,31.799999999999997,2,-1,3,-3,-3,Carbohydrate,No gap,4.779492794730947,0,-4.779492794730947,0.08264349631241612,0.939741959353124,Downregulated,LEDU
Feature0105,"6-Methoxy-1,2,4-benzenetriol",C7 H8 O4,156.04229,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Phenylalanine, tyrosine and tryptophan biosynthesis;Other","6-Methoxy-1,2,4-benzenetriol",7,8,0,4,0,0,0,1.1428571428571428,0.5714285714285714,0,60.3,4,0,0,0.4,0,Phenol,No gap,4.867573380326867,9.092511416449717,4.22493803612285,0.38563042722764407,0.939741959353124,Upregulated,LEDU
Feature0330,"pentane-1,2,3,4,5-pentol",C5 H12 O5,152.06848,Metabolic pathways;ABC transporters;Other,"pentane-1,2,3,4,5-pentol",5,12,0,5,0,0,0,2.4,1,-0.4000000000000003,71.7,0,-5,-Inf,-1,-5,Carbohydrate,Missing ions,2.9533069279352135,8.891410919079133,5.93810399114392,0.356623546321714,0.939741959353124,Upregulated,LEDU
Feature0298,"N,N-dimethyl-N'-(3-phenyl[1,2,4]triazolo[4,3-b]pyridazin-6-yl)iminoformamide",C14 H14 N6,266.12669,Metabolic pathways;Biosynthesis of cofactors;Other,"N,N-dimethyl-N'-(3-phenyl[1,2,4]triazolo[4,3-b]pyridazin-6-yl)iminoformamide",14,14,6,0,0,0,0,1,0,0.2857142857142856,52.15714285714286,11,11,0.625,0.625,5,Unsaturated HC,No gap,2.455063786432093,0,-2.455063786432093,0.16465407568916324,0.939741959353124,Downregulated,LEDU
Feature0102,"6-chloro-2-(3-ethyl-5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)-4-phenylquinoline",C31 H32 Cl N,453.2239,NA,"6-chloro-2-(3-ethyl-5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)-4-phenylquinoline",32,32,1,0,1,0,0,1,0,-0.90625,86.128125,17.5,17.5,0.532258064516129,0.532258064516129,16.5,Unsaturated HC,No gap,1.4530165121273066,0,-1.4530165121273066,0.33428194339465733,0.939741959353124,Downregulated,LEDU
Feature0094,"5-acetamido-3,5-dideoxy-L-arabino-hept-2-ulopyranosonic acid",C9 H15 N O7,249.08483,NA,"5-acetamido-3,5-dideoxy-L-arabino-hept-2-ulopyranosonic acid",9,15,1,7,0,0,0,1.6666666666666667,0.7777777777777778,0.22222222222222232,53.96666666666666,3,-4,-5,-0.3333333333333333,-5,Carbohydrate,No gap,1.7345261538421866,0,-1.7345261538421866,0.33428194339465733,0.939741959353124,Downregulated,LEDU
Feature0075,"3-Morpholino-4-tetrahydro-1H-pyrrol-1-ylcyclobut-3-ene-1,2-dione",C12 H16 N2 O3,236.11602,NA,"3-Morpholino-4-tetrahydro-1H-pyrrol-1-ylcyclobut-3-ene-1,2-dione",12,16,2,3,0,0,0,1.3333333333333333,0.25,-0.33333333333333304,69.79999999999998,6,3,0.14285714285714285,0.29411764705882354,1,Phenol,No gap,0,2.8158987438684338,2.8158987438684338,0.36321746764912255,0.939741959353124,Upregulated,LEDU
Feature0055,"2-[9-(Hydroxyimino)-3,6-diazatricyclo[4.3.1.1~3,8~]undec-1-yl]ethyl acetate",C13 H21 N3 O3,267.15832,NA,"2-[9-(Hydroxyimino)-3,6-diazatricyclo[4.3.1.1~3,8~]undec-1-yl]ethyl acetate",13,21,3,3,0,0,0,1.6153846153846154,0.2307692307692308,-0.4615384615384617,73.45384615384616,5,2,-0.14285714285714285,0.0588235294117647,-1,Lipid,Missing ions,0,3.9391783310427666,3.9391783310427666,0.36321746764912255,0.939741959353124,Upregulated,LEDU
Feature0231,"Hexahydro[1,2,4]triazino[5,6-e][1,2,4]triazine-3,6(2H,4H)-dione",C4 H8 N6 O2,172.07118,NA,"Hexahydro[1,2,4]triazino[5,6-e][1,2,4]triazine-3,6(2H,4H)-dione",4,8,6,2,0,0,0,2,0.5,3.5,-39.45,4,2,1,1,-4,Protein,No gap,0,3.0813956451835334,3.0813956451835334,0.36321746764912255,0.939741959353124,Upregulated,LEDU
Feature0091,4-Methoxycinnamaldehyde,C10 H10 O2,162.0681,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,4-Methoxycinnamaldehyde,10,10,0,2,0,0,0,1,0.2,-0.5999999999999996,77.39999999999999,6,4,0.5,0.5555555555555556,4,Phenol,No gap,1.3771163245473133,0,-1.3771163245473133,0.33428194339465733,0.939741959353124,Downregulated,LEDU
Feature0024,NA,C11 H20 N4 O3,256.15356,NA,Feature0024,11,20,4,3,0,0,0,1.818181818181818,0.2727272727272727,-0.18181818181818168,65.48181818181817,4,1,-0.75,-0.2727272727272727,-3,Lipid,No gap,3.07243020124338,0,-3.07243020124338,0.08252581641373294,0.939741959353124,Downregulated,LEDU
Feature0315,Nonylbenzene,C15 H24,204.18777,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Nonylbenzene,15,24,0,0,0,0,0,1.6,0,-1.5999999999999996,105.89999999999998,4,4,0.26666666666666666,0.26666666666666666,4,Lipid,No gap,1.4932452139268133,0,-1.4932452139268133,0.33428194339465733,0.939741959353124,Downregulated,LEDU
Feature0344,pyroglutamine,C5 H8 N2 O2,128.05857,Metabolic pathways;Cyanoamino acid metabolism;Other,pyroglutamine,5,8,2,2,0,0,0,1.6,0.4,0.3999999999999999,48.9,3,1,-1,0,-1,Protein,No gap,3.2069252363306533,0,-3.2069252363306533,0.16431987498165343,0.939741959353124,Downregulated,LEDU
Feature0339,"Propane, 1,3-diacetoxy-2-acetoxymethyl-2-nitro-",C10 H15 N O8,277.07983,NA,"Propane, 1,3-diacetoxy-2-acetoxymethyl-2-nitro-",10,15,1,8,0,0,0,1.5,0.8,0.3999999999999999,48.9,4,-4,-5,-0.2,-5,Carbohydrate,No gap,1.68266378389954,0,-1.68266378389954,0.33428194339465744,0.939741959353124,Downregulated,LEDU
Feature0279,Methionine sulfoxide,C5 H11 N O3 S,165.04599,Metabolic pathways;Other,Methionine sulfoxide,5,11,1,3,0,1,0,2.2,0.6,0,60.3,1,-2,-Inf,-1.6666666666666667,-4,Amino Sugar,No gap,5.107856190366913,0,-5.107856190366913,0.08242079790237739,0.939741959353124,Downregulated,LEDU
Feature0237,Inosine-5'-monophosphate (IMP),C10 H13 N4 O8 P,348.04715,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;Other,Inosine-5'-monophosphate (IMP),10,13,4,8,0,0,1,1.3,0.8,1,31.799999999999997,7,-1,2,-2,-6,Other,No gap,3.34337859791854,0,-3.34337859791854,0.16439475620484822,0.939741959353124,Downregulated,LEDU
Feature0037,"1,4-Anhydro-1-(2,4-dioxo-1,2,3,4-tetrahydro-5-pyrimidinyl)-5-O-phosphonopentitol",C9 H13 N2 O9 P,324.03593,Metabolic pathways;Biosynthesis of cofactors;Other,"1,4-Anhydro-1-(2,4-dioxo-1,2,3,4-tetrahydro-5-pyrimidinyl)-5-O-phosphonopentitol",9,13,2,9,0,0,1,1.4444444444444444,1,0.6666666666666665,41.3,5,-4,2.3333333333333335,-1.6666666666666667,-7,Other,No gap,3.3701712633666,0,-3.3701712633666,0.16435824671911314,0.939741959353124,Downregulated,LEDU
Feature0284,Methyl glycyl-N~5~-(diaminomethylene)-L-ornithinate,C9 H19 N5 O3,245.14919,Metabolic pathways;Other,Methyl glycyl-N~5~-(diaminomethylene)-L-ornithinate,9,19,5,3,0,0,0,2.111111111111111,0.3333333333333333,0.22222222222222232,53.96666666666666,3,0,-5,-1.4,-5,Protein,No gap,1.4480644513271066,0,-1.4480644513271066,0.33428194339465755,0.939741959353124,Downregulated,LEDU
Feature0262,Leu-ala,C9 H18 N2 O3,202.1317,NA,Leu-ala-peak3,9,18,2,3,0,0,0,2,0.3333333333333333,-0.666666666666667,79.30000000000001,2,-1,-0.75,-0.2727272727272727,-3,Protein,No gap,4.81050690566884,0,-4.81050690566884,0.08243242364064404,0.939741959353124,Downregulated,LEDU
Feature0184,Azobenzene,C12 H10 N2,182.08444,Biosynthesis of secondary metabolites;Other,Azobenzene,12,10,2,0,0,0,0,0.8333333333333334,0,-0.33333333333333304,69.79999999999998,9,9,0.7,0.7,7,Unsaturated HC,No gap,1.1474758977066335,0,-1.1474758977066335,0.33428194339465733,0.939741959353124,Downregulated,LEDU
Feature0154,[Similar to: N(6)-OH-Me-Adenosine; ΔMass: 132.0422 Da],C16 H23 N5 O9,429.14955,NA,[Similar to: N(6)-OH-Me-Adenosine; ΔMass: 132.0422 Da],16,23,5,9,0,0,0,1.4375,0.5625,0.625,42.4875,8,-1,-3,-0.2307692307692308,-6,Phenol,No gap,1.4116940528614867,0,-1.4116940528614867,0.33428194339465767,0.939741959353124,Downregulated,LEDU
Feature0145,[Similar to: D-(+)-Glucose; ΔMass: 31.0422 Da],C7 H17 N O6,211.10558,NA,[Similar to: D-(+)-Glucose; ΔMass: 31.0422 Da],7,17,1,6,0,0,0,2.4285714285714284,0.8571428571428571,-0.2857142857142856,68.44285714285714,0,-6,-Inf,-1.3333333333333333,-7,Carbohydrate,No gap,1.2997582387066866,0,-1.2997582387066866,0.33428194339465733,0.939741959353124,Downregulated,LEDU
Feature0085,"4-amino-4-carboxy-2,2,6,6-tetramethyl-1-piperidinyloxy",C10 H20 N2 O3,216.14739,NA,"4-amino-4-carboxy-2,2,6,6-tetramethyl-1-piperidinyloxy-peak2",10,20,2,3,0,0,0,2,0.3,-0.7999999999999998,83.1,2,-1,-0.6,-0.2307692307692308,-3,Lipid,No gap,1.5899845042297334,0,-1.5899845042297334,0.33428194339465733,0.939741959353124,Downregulated,LEDU
Feature0044,1-Amino-1-deoxyhexitol,C6 H15 N O5,181.09505,NA,1-Amino-1-deoxyhexitol,6,15,1,5,0,0,0,2.5,0.8333333333333334,-0.33333333333333304,69.79999999999998,0,-5,-Inf,-1.4,-6,Carbohydrate,No gap,1.31994075945488,0,-1.31994075945488,0.33428194339465733,0.939741959353124,Downregulated,LEDU
Feature0364,α-Eleostearic acid,C18 H30 O2,278.22457000000003,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Other,α-Eleostearic acid,18,30,0,2,0,0,0,1.6666666666666667,0.1111111111111111,-1.4444444444444446,101.46666666666668,4,2,0.125,0.17647058823529413,2,Lipid,No gap,1.4707251573791733,0,-1.4707251573791733,0.33428194339465755,0.939741959353124,Downregulated,LEDU
Feature0304,N-Acetyl-L-histidine,C8 H11 N3 O3,197.08006,NA,N-Acetyl-L-histidine,8,11,3,3,0,0,0,1.375,0.375,0.5,46.05,5,2,-0.5,0.14285714285714285,-1,Phenol,No gap,3.0126853362918267,0,-3.0126853362918267,0.16451626124969446,0.939741959353124,Downregulated,LEDU
Feature0289,Mevalonolactone,C6 H10 O3,130.06297,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Degradation of aromatic compounds;Other,Mevalonolactone,6,10,0,3,0,0,0,1.6666666666666667,0.5,-0.666666666666667,79.30000000000001,2,-1,-0.3333333333333333,0.1111111111111111,-1,Protein,No gap,1.30558135438462,0,-1.30558135438462,0.33428194339465733,0.939741959353124,Downregulated,LEDU
Feature0238,Isoamylamine,C5 H13 N,87.10481,NA,Isoamylamine,5,13,1,0,0,0,0,2.6,0,-2,117.3,0,0,-0.25,-0.25,-1,Other,No gap,1.37193951830202,0,-1.37193951830202,0.33428194339465755,0.939741959353124,Downregulated,LEDU
Feature0226,Glycerylphosphorylethanolamine,C5 H14 N O6 P,215.05586,Metabolic pathways;Other,Glycerylphosphorylethanolamine,5,14,1,6,0,0,1,2.8,1.2,-0.7999999999999998,83.1,0,-6,2.6666666666666665,-Inf,-8,Other,No gap,3.1320047447981536,0,-3.1320047447981536,0.16444429358263613,0.939741959353124,Downregulated,LEDU
Feature0210,D-PANTOTHENIC ACID,C9 H17 N O5,219.11067,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Other,D-PANTOTHENIC ACID,9,17,1,5,0,0,0,1.8888888888888888,0.5555555555555556,-0.44444444444444464,72.96666666666667,2,-3,-1.3333333333333333,-0.2727272727272727,-4,Amino Sugar,No gap,1.6173192929608866,0,-1.6173192929608866,0.33428194339465733,0.939741959353124,Downregulated,LEDU
Feature0204,Cytidine 5'-diphosphocholine,C14 H26 N4 O11 P2,488.10744,Metabolic pathways;Other,Cytidine 5'-diphosphocholine,14,26,4,11,0,0,2,1.8571428571428572,0.7857142857142857,-0.14285714285714324,64.37142857142858,5,-6,4,-2.6,-12,Carbohydrate,No gap,1.4078941049873268,0,-1.4078941049873268,0.33428194339465733,0.939741959353124,Downregulated,LEDU
Feature0177,Agmatine,C5 H14 N4,130.12182,Metabolic pathways;Biosynthesis of various plant secondary metabolites;Other,Agmatine,5,14,4,0,0,0,0,2.8,0,-0.4000000000000003,71.7,1,1,-3,-3,-3,Other,No gap,1.5500993667875869,0,-1.5500993667875869,0.3342819433946572,0.939741959353124,Downregulated,LEDU
Feature0170,[Similar to: Triethyl phosphate; ΔMass: 17.9743 Da],C5 H13 O6 P,200.04505,NA,[Similar to: Triethyl phosphate; ΔMass: 17.9743 Da],5,13,0,6,0,0,1,2.6,1.2,-1.2000000000000002,94.5,0,-6,3.5,-4,-7,Other,No gap,1.3853658518167866,0,-1.3853658518167866,0.33428194339465733,0.939741959353124,Downregulated,LEDU
Feature0101,6-Aminocaproic acid,C6 H13 N O2,131.09459,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Tropane, piperidine and pyridine alkaloid biosynthesis;Cyanoamino acid metabolism;Other",6-Aminocaproic acid,6,13,1,2,0,0,0,2.1666666666666665,0.3333333333333333,-1,88.8,1,-1,-0.6666666666666666,-0.25,-2,Protein,No gap,1.3113626761279067,0,-1.3113626761279067,0.33428194339465733,0.939741959353124,Downregulated,LEDU
Feature0061,2-O-(beta-D-glucosyl)-sn-glycerol 3-phosphate,C9 H19 O11 P,334.06664,NA,2-O-(beta-D-glucosyl)-sn-glycerol 3-phosphate,9,19,0,11,0,0,1,2.111111111111111,1.2222222222222223,-0.22222222222222232,66.63333333333333,1,-10,3.6666666666666665,-2.2,-11,Carbohydrate,No gap,1.4454475390124868,0,-1.4454475390124868,0.33428194339465733,0.939741959353124,Downregulated,LEDU
Feature0060,2-Methylhippuric Acid,C10 H11 N O3,193.0739,Other,2-Methylhippuric Acid,10,11,1,3,0,0,0,1.1,0.3,-0.20000000000000015,66,6,3,0.3333333333333333,0.4666666666666667,2,Phenol,No gap,1.6378648634256001,0,-1.6378648634256001,0.33428194339465733,0.939741959353124,Downregulated,LEDU
Feature0350,Thymine,C5 H6 N2 O2,126.04289,Metabolic pathways;Other,Thymine,5,6,2,2,0,0,0,1.2,0.4,0.7999999999999998,37.5,4,2,0,0.5,0,Phenol,No gap,1.5259166318845268,0,-1.5259166318845268,0.33428194339465733,0.939741959353124,Downregulated,LEDU
Feature0314,Nicotinic acid,C6 H5 N O2,123.03198,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;Degradation of aromatic compounds;Tropane, piperidine and pyridine alkaloid biosynthesis;Other",Nicotinic acid,6,5,1,2,0,0,0,0.8333333333333334,0.3333333333333333,0.3333333333333335,50.8,5,3,0.6666666666666666,0.75,2,Phenol,No gap,1.5319598177425533,0,-1.5319598177425533,0.33428194339465733,0.939741959353124,Downregulated,LEDU
Feature0166,[Similar to: NP-017684; ΔMass: -74.2515 Da],C30 H44 O15 P2,706.21453,NA,[Similar to: NP-017684; ΔMass: -74.2515 Da],30,44,0,15,0,0,2,1.4666666666666666,0.5,-0.7999999999999998,83.1,10,-5,-0.5384615384615384,0.02439024390243902,-7,Phenol,No gap,3.3807455046695467,0,-3.3807455046695467,0.1643305691000355,0.939741959353124,Downregulated,LEDU
Feature0285,methyl N-acetylneuraminate,C12 H21 N O9,323.12167,NA,methyl N-acetylneuraminate-peak1,12,21,1,9,0,0,0,1.75,0.75,0,60.3,3,-6,-3.5,-0.38461538461538464,-7,Carbohydrate,No gap,1.6087843854340067,0,-1.6087843854340067,0.33428194339465733,0.939741959353124,Downregulated,LEDU
Feature0128,[Similar to: 3-[1-(dimethylamino)-1H-pyrrol-2-yl]-2-(2-furylcarbonyl)acrylonitrile; ΔMass: 200.0995 Da],C19 H29 N5 O8,455.20029,NA,[Similar to: 3-[1-(dimethylamino)-1H-pyrrol-2-yl]-2-(2-furylcarbonyl)acrylonitrile; ΔMass: 200.0995 Da],19,29,5,8,0,0,0,1.5263157894736843,0.42105263157894735,0.10526315789473673,57.3,8,0,-0.8333333333333334,-0.1,-5,Protein,Missing ions,9.557153932993153,4.7576272208253165,-4.799526712167836,0.4385650124478464,0.939741959353124,Downregulated,LEDU
Feature0126,"[Similar to: 3,5-Di(acetyloxy)-2-[(acetyloxy)methyl]-6-(2H-1,2,3,4-tetraazol-5-yl)tetrahydro-2H-pyran-4-yl acetate; ΔMass: -24.9853 Da]",C12 H25 N O12,375.1377,NA,"[Similar to: 3,5-Di(acetyloxy)-2-[(acetyloxy)methyl]-6-(2H-1,2,3,4-tetraazol-5-yl)tetrahydro-2H-pyran-4-yl acetate; ΔMass: -24.9853 Da]",12,25,1,12,0,0,0,2.0833333333333335,1,0.16666666666666652,55.55,1,-11,12,-1.2,-12,Carbohydrate,No gap,1.4237124916833734,0,-1.4237124916833734,0.3342819433946572,0.939741959353124,Downregulated,LEDU
Feature0015,NA,C35 H63 N O3,545.48106,NA,Feature0015,35,63,1,3,0,0,0,1.8,0.08571428571428572,-1.5428571428571427,104.27142857142856,5,2,0.03225806451612903,0.07692307692307693,1,Lipid,No gap,1.70632865760292,0,-1.70632865760292,0.33428194339465767,0.939741959353124,Downregulated,LEDU
Feature0010,NA,C10 H17 N7 O8,363.11421,NA,Feature0010,10,17,7,8,0,0,0,1.7,0.8,2,3.299999999999997,6,-2,1.8,5,-9,Carbohydrate,No gap,1.5561799594144667,0,-1.5561799594144667,0.33428194339465733,0.939741959353124,Downregulated,LEDU
Feature0286,methyl N-acetylneuraminate,C12 H21 N O9,323.12172,NA,methyl N-acetylneuraminate-peak2,12,21,1,9,0,0,0,1.75,0.75,0,60.3,3,-6,-3.5,-0.38461538461538464,-7,Carbohydrate,No gap,1.89641010225298,0,-1.89641010225298,0.33428194339465733,0.939741959353124,Downregulated,LEDU
Feature0089,"4-Hydroxy-N-(2-hydroxy-8-methyl-4-oxo-7-{[(2R,3R,4R,5R)-3,4,5-trihydroxy-6,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-4H-chromen-3-yl)-3-(3-methyl-2-buten-1-yl)benzamide",C29 H33 N O10,555.21068,Metabolic pathways;Biosynthesis of secondary metabolites;Other,"4-Hydroxy-N-(2-hydroxy-8-methyl-4-oxo-7-{[(2R,3R,4R,5R)-3,4,5-trihydroxy-6,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-4H-chromen-3-yl)-3-(3-methyl-2-buten-1-yl)benzamide",29,33,1,10,0,0,0,1.137931034482759,0.3448275862068966,-0.3448275862068968,70.12758620689655,14,4,0.16666666666666666,0.34782608695652173,3,Phenol,No gap,1.16772326546048,0,-1.16772326546048,0.33428194339465733,0.939741959353124,Downregulated,LEDU
Feature0299,N-(3-Carboxypropanoyl)-5-hydroxynorvaline,C9 H15 N O6,233.08993,NA,N-(3-Carboxypropanoyl)-5-hydroxynorvaline,9,15,1,6,0,0,0,1.6666666666666667,0.6666666666666666,0,60.3,3,-3,-2,-0.2,-4,Amino Sugar,No gap,1.8522775392300066,0,-1.8522775392300066,0.33428194339465733,0.939741959353124,Downregulated,LEDU
Feature0165,[Similar to: NP-016755; ΔMass: -960.7865 Da],C5 H8 N6 O4,216.06096,NA,[Similar to: NP-016755; ΔMass: -960.7865 Da]-peak3,5,8,6,4,0,0,0,1.6,0.8,3.6,-42.30000000000001,5,1,1,1,-5,Carbohydrate,No gap,3.50823327543196,0,-3.50823327543196,0.1643275660403555,0.939741959353124,Downregulated,LEDU
Feature0140,"[Similar to: 6-(2-hydroxy-3-methyl-3-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}butyl)-5,7-dimethoxy-2H-chromen-2-one; ΔMass: -88.0700 Da]",C11 H14 N10 O6,382.10881,NA,"[Similar to: 6-(2-hydroxy-3-methyl-3-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}butyl)-5,7-dimethoxy-2H-chromen-2-one; ΔMass: -88.0700 Da]",11,14,10,6,0,0,0,1.2727272727272727,0.5454545454545454,2.5454545454545454,-12.24545454545455,10,4,1.2,1.5,-6,Phenol,No gap,1.5309038720791934,0,-1.5309038720791934,0.33428194339465733,0.939741959353124,Downregulated,LEDU
Feature0131,"[Similar to: 4-[(1S,3aR,4S,6aR)-4-(4-hydroxy-3-methoxyphenyl)-hexahydrofuro[3,4-c]furan-1-yl]-2-methoxyphenol; ΔMass: 22.1487 Da]",C19 H36 N6 O2,380.29029,NA,"[Similar to: 4-[(1S,3aR,4S,6aR)-4-(4-hydroxy-3-methoxyphenyl)-hexahydrofuro[3,4-c]furan-1-yl]-2-methoxyphenol; ΔMass: 22.1487 Da]",19,36,6,2,0,0,0,1.894736842105263,0.10526315789473684,-0.7368421052631575,81.29999999999998,5,3,-0.2727272727272727,-0.16666666666666666,-3,Lipid,No gap,3.68247012964602,0,-3.68247012964602,0.16432293398567113,0.939741959353124,Downregulated,LEDU
Feature0017,NA,C11 H21 N O8 S,327.09887,Other,Feature0017,11,21,1,8,0,1,0,1.9090909090909092,0.7272727272727273,0,60.3,2,-6,-8,-0.8,-8,Carbohydrate,No gap,1.5130273845099198,0,-1.5130273845099198,0.33428194339465733,0.939741959353124,Downregulated,LEDU
Feature0294,MFCD00634809,C16 H20 N2 O3,288.14736,NA,MFCD00634809,16,20,2,3,0,0,0,1.25,0.1875,-0.5,74.55,8,5,0.2727272727272727,0.36,3,Phenol,No gap,1.2186408463185265,0,-1.2186408463185265,0.33428194339465733,0.939741959353124,Downregulated,LEDU
Feature0226,Glycerylphosphorylethanolamine,C5 H14 N O6 P,215.05586,Metabolic pathways;Other,Glycerylphosphorylethanolamine,5,14,1,6,0,0,1,2.8,1.2,-0.7999999999999998,83.1,0,-6,2.6666666666666665,-Inf,-8,Other,Missing ions,3.1320047447981536,0,-3.1320047447981536,0.16444429358263613,0.939741959353124,Downregulated,LEDU
Feature0211,Di(2-Tetrahydrofurylmethyl)amine,C10 H19 N O2,185.14155,NA,Di(2-Tetrahydrofurylmethyl)amine,10,19,1,2,0,0,0,1.9,0.2,-1.2000000000000002,94.5,2,0,-0.14285714285714285,0,-1,Lipid,No gap,1.3681968493590067,0,-1.3681968493590067,0.33428194339465755,0.939741959353124,Downregulated,LEDU
Feature0040,"1-(3,4-dimethoxyphenyl)ethan-1-one oxime",C10 H13 N O3,195.08957,Other,"1-(3,4-dimethoxyphenyl)ethan-1-one oxime",10,13,1,3,0,0,0,1.3,0.3,-0.4000000000000003,71.7,5,2,0.16666666666666666,0.3333333333333333,1,Phenol,No gap,1.4524088688962467,0,-1.4524088688962467,0.33428194339465744,0.939741959353124,Downregulated,LEDU
Feature0151,[Similar to: Irgarol 1051; ΔMass: -56.0639 Da],C6 H15 N O4 S,197.07222,NA,[Similar to: Irgarol 1051; ΔMass: -56.0639 Da],6,15,1,4,0,1,0,2.5,0.6666666666666666,-0.33333333333333304,69.79999999999998,0,-4,-Inf,-2,-6,Other,No gap,0,3.98714739628065,3.98714739628065,0.36321746764912255,0.939741959353124,Upregulated,LEDU
Feature0055,"2-[9-(Hydroxyimino)-3,6-diazatricyclo[4.3.1.1~3,8~]undec-1-yl]ethyl acetate",C13 H21 N3 O3,267.15832,NA,"2-[9-(Hydroxyimino)-3,6-diazatricyclo[4.3.1.1~3,8~]undec-1-yl]ethyl acetate",13,21,3,3,0,0,0,1.6153846153846154,0.2307692307692308,-0.4615384615384617,73.45384615384616,5,2,-0.14285714285714285,0.0588235294117647,-1,Lipid,No gap,0,3.9391783310427666,3.9391783310427666,0.36321746764912255,0.939741959353124,Upregulated,LEDU
Feature0027,"(1R,4aS,5R,8aS)-5-(5-hydroxy-3-methylpentyl)-1,4a-dimethyl-6-methylidene-decahydronaphthalene-1-carboxylic acid",C20 H34 O3,322.25075,Metabolic pathways;Biosynthesis of secondary metabolites;Other,"(1R,4aS,5R,8aS)-5-(5-hydroxy-3-methylpentyl)-1,4a-dimethyl-6-methylidene-decahydronaphthalene-1-carboxylic acid",20,34,0,3,0,0,0,1.7,0.15,-1.4000000000000004,100.20000000000002,4,1,0.0588235294117647,0.13513513513513514,1,Lipid,No gap,0,3.1285770355458666,3.1285770355458666,0.36321746764912255,0.939741959353124,Upregulated,LEDU
Feature0235,Indole-3-acetic acid,C10 H9 N O2,175.06333,Metabolic pathways;Other,Indole-3-acetic acid,10,9,1,2,0,0,0,0.9,0.2,-0.20000000000000015,66,7,5,0.5714285714285714,0.625,4,Phenol,No gap,1.51908158859134,0,-1.51908158859134,0.3342819433946572,0.939741959353124,Downregulated,LEDU
Feature0095,"5-Amino-6,6-bis(ethylsulfanyl)-1,2,3,4-hexanetetrol",C10 H23 N O4 S2,285.10595,NA,"5-Amino-6,6-bis(ethylsulfanyl)-1,2,3,4-hexanetetrol",10,23,1,4,0,2,0,2.3,0.4,-0.7999999999999998,83.1,0,-4,-2.3333333333333335,-1,-7,Protein,No gap,1.5971186489346068,0,-1.5971186489346068,0.3342819433946572,0.939741959353124,Downregulated,LEDU
Feature0034,.alpha.-Glucoheptitol,C7 H16 O7,212.08956,NA,.alpha.-Glucoheptitol,7,16,0,7,0,0,0,2.2857142857142856,1,-0.2857142857142856,68.44285714285714,0,-7,-Inf,-1,-7,Carbohydrate,No gap,1.48362649244686,0,-1.48362649244686,0.33428194339465733,0.939741959353124,Downregulated,LEDU
Feature0030,"(2S)-3-Phenyl-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)propanoic acid (non-preferred name)",C15 H21 N O7,327.13187,NA,"(2S)-3-Phenyl-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)propanoic acid (non-preferred name)",15,21,1,7,0,0,0,1.4,0.4666666666666667,-0.2666666666666666,67.89999999999999,6,-1,-0.2857142857142857,0.14285714285714285,-2,Phenol,Missing ions,1.6910652646288267,0,-1.6910652646288267,0.33428194339465755,0.939741959353124,Downregulated,LEDU
Feature0325,NP-021733,C7 H13 N O2,143.09464,ABC transporters,NP-021733,7,13,1,2,0,0,0,1.8571428571428572,0.2857142857142857,-0.8571428571428568,84.72857142857141,2,0,-0.25,0,-1,Lipid,No gap,1.1918756045369734,0,-1.1918756045369734,0.3342819433946572,0.939741959353124,Downregulated,LEDU
Feature0212,Diacetylene glycol,C6 H6 O2,110.03673,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,Diacetylene glycol,6,6,0,2,0,0,0,1,0.3333333333333333,-0.33333333333333304,69.79999999999998,4,2,0.5,0.6,2,Phenol,No gap,1.5563845555154734,0,-1.5563845555154734,0.3342819433946572,0.939741959353124,Downregulated,LEDU
Feature0132,"[Similar to: 4-[(7R,11S,14S,16R)-14-[(4-methoxy-6-methyl-5-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-({[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}oxan-2-yl)oxy]-7,11-dimethyl-2-oxapentacyclo[8.8.0.0Âa,Âl.0Âl,â·.0ÂaÂa,Âaâ¶]octadec-5-en-6-yl]-2,5-dihydrofuran-2-one; ΔMass: -155.1501 Da]",C25 H41 N5 O17,683.24858,NA,"[Similar to: 4-[(7R,11S,14S,16R)-14-[(4-methoxy-6-methyl-5-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-({[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}oxan-2-yl)oxy]-7,11-dimethyl-2-oxapentacyclo[8.8.0.0Âa,Âl.0Âl,â·.0ÂaÂa,Âaâ¶]octadec-5-en-6-yl]-2,5-dihydrofuran-2-one; ΔMass: -155.1501 Da]-peak1",25,41,5,17,0,0,0,1.64,0.68,0.31999999999999984,51.18,8,-9,-4.666666666666667,-0.4782608695652174,-14,Amino Sugar,No gap,1.6835079615257134,0,-1.6835079615257134,0.33428194339465733,0.939741959353124,Downregulated,LEDU
Feature0088,4-Hydroxy-3-nitrosobenzamide,C7 H6 N2 O3,166.03788,NA,4-Hydroxy-3-nitrosobenzamide,7,6,2,3,0,0,0,0.8571428571428571,0.42857142857142855,0.8571428571428572,35.87142857142857,6,3,0.5,0.7142857142857143,1,Phenol,No gap,1.2476033814492935,0,-1.2476033814492935,0.33428194339465733,0.939741959353124,Downregulated,LEDU
Feature0316,NP-003553,C20 H34 O4,338.24574,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NP-003553,20,34,0,4,0,0,0,1.7,0.2,-1.2999999999999998,97.35,4,0,0,0.1111111111111111,0,Lipid,No gap,0,3.3958164644045,3.3958164644045,0.36321746764912255,0.939741959353124,Upregulated,LEDU
Feature0081,"4,5-Dideoxypentonic acid",C5 H10 O4,134.05785,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Other,"4,5-Dideoxypentonic acid",5,10,0,4,0,0,0,2,0.8,-0.4000000000000003,71.7,1,-3,-3,-0.3333333333333333,-3,Carbohydrate,No gap,0,4.412469004687433,4.412469004687433,0.36321746764912255,0.939741959353124,Upregulated,LEDU
Feature0080,3696,C10 H14 O2,166.09939,Metabolic pathways;Biosynthesis of secondary metabolites;Other,3696,10,14,0,2,0,0,0,1.4,0.2,-1,88.8,4,2,0.25,0.3333333333333333,2,Phenol,No gap,0,3.3962554311067166,3.3962554311067166,0.36321746764912255,0.939741959353124,Upregulated,LEDU
Feature0072,3-hydroxy-cis-5-octenoylcarnitine,C15 H27 N O5,301.18898,NA,3-hydroxy-cis-5-octenoylcarnitine,15,27,1,5,0,0,0,1.8,0.3333333333333333,-0.9333333333333336,86.9,3,-2,-0.3333333333333333,-0.04347826086956521,-3,Protein,No gap,0,3.229888279087,3.229888279087,0.36321746764912255,0.939741959353124,Upregulated,LEDU
